ArticleCurrent research in pharmacology and drug discovery2022

GSK2606414 attenuates PERK/p-eIF2α/ATF4/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells.

Chayanika Gundu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.